TNX-1840

N/A

Report date: 2023/06/27 15:01:23

Base Information

Drug NameTNX-1840
Drug Alias NameTNX1840
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulantsSARS-CoV-2 Spike glycoprotein receptor binding domain antagonists
TargetsSARS-CoV-2 Spike glycoprotein receptor binding domain
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTonix Pharmaceuticals Holding Corp
China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Holding Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A